Shanghai Haoyuan Chemexpress Co.Ltd(688131) notes to financial statements
12、 Commitments and contingencies
1. Commitments
None.
2. Contingencies
None.
13、 Events after the balance sheet date
1. Important non adjustment matters
Impact assessment of New Coronavirus pneumonia outbreak
The repeated outbreak of New Coronavirus has caused various countries and regions in the world to suffer from different degrees of influence. The company pays close attention to the development of covid-19 pneumonia and its impact on the company, formulates an effective epidemic emergency prevention and control plan, and implements various protective measures to ensure safe production while fighting the epidemic.
2. Profit distribution
On April 20, 2022, the company held the fifth meeting of the third board of directors and passed the proposal on profit distribution plan in 2021. The company plans to distribute cash dividends of RMB 5.30 (including tax) to all shareholders for every 10 shares based on the total share capital registered on the date of equity distribution; It is proposed to increase 4 shares for every 10 shares to all shareholders with capital reserve. The proposal has yet to be considered and approved by the general meeting of shareholders.
As of December 31, 2021, the total share capital of the company was 74342007 shares, with a total increase of 29736803 shares. After the increase, the total share capital of the company increased to 104078810 shares. The number of converted shares is the company's rounding income according to the actual calculation results. The final number of converted shares is subject to the number of shares disclosed in the announcement on the implementation of equity distribution issued separately after the company has completed the legal procedures.
14、 Other important matters
None.
15、 Notes to important items in the financial statements of the parent company
1. Accounts receivable
(1) Disclosure by aging
Shanghai Haoyuan Chemexpress Co.Ltd(688131) notes to financial statements
Project closing balance opening balance
Within 1 year 68774554045319450424
1-2 years 362886733451327
2-3 years 3451327 -
More than 3 years - 10000000
Total book balance of accounts receivable 69171954045332901751
Less: bad debt provision 352856168276662786
Total book value of accounts receivable 65643392365056238965
(2) Classified disclosure by bad debt accrual method
Ending balance
Category book balance bad debt provision
Accrual proportion book value proportion (%)
Withdrawing bad debt reserves by single item -————
Bad debt reserves withdrawn by portfolio 6917195404 100.00352856168 5.106564339236
1. Combination 1 - accounts receivable from customers 6917195404 100.00352856168 5.106564339236
Total 6917195404 100.00352856168 5.106564339236
Specific instructions for the provision of bad debt reserves in the current period:
① Accounts receivable with bad debt provision withdrawn according to combination 1 - accounts receivable from customers
Ending balance
Aging
Proportion of bad debt provision of book balance (%)
Within 1 year 6877455404343872770 5.00
1-2 years 362886737257735 20.00
2-3 years 34513271725663 50.00
More than 3 years - 100.00
Total 6917195404352856168 5.10
See note III and 10 for the recognition criteria and instructions of withdrawing bad debt reserves by portfolio.
(3) Bad debt provision
① Changes in bad debt reserves in the current period
Shanghai Haoyuan Chemexpress Co.Ltd(688131) notes to financial statements
Current change amount
Category opening balance closing balance
Withdrawal or reversal, write off or write off
Accounts receivable 276662786861933821000 China Tianying Inc(000035) 2856168
(4) Accounts receivable actually written off in the current period
Current amount of the project
Actual accounts receivable written off 10000000
(5) Accounts receivable with the top five balances collected by debtors at the end of the period
Company name proportion of ending balance of accounts receivable to total ending balance of bad debt provision of accounts receivable (%)
Yingen biopharmaceutical (Suzhou) Co., Ltd. 881800000 12.7544090000 Division
Zhejiang chemical import and Export Co., Ltd. 766100000 11.0738305000
ChemScene LLC 6,764041.33 9.78 338202.07
Zhejiang yuannuotong Pharmaceutical Technology Co., Ltd. 560809000 8.1128040450 company
Huizhou Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) Pharmaceutical Co., Ltd. 503395000 7.2825169750
Total 3388508133 48.99169425407
(6) In the current period, the company has no accounts receivable derecognized due to the transfer of financial assets.
(7) In the current period, the company has no transferred accounts receivable and continues to be involved in the amount of assets and liabilities formed.
2. Other receivables
(1) Classified listing
Project closing balance opening balance
Interest receivable——
Dividends receivable——
Other receivables 249102593999517493655
Total 249102593999517493655
(2) Other receivables
① Disclosure by aging
Shanghai Haoyuan Chemexpress Co.Ltd(688131) notes to financial statements
Project closing balance opening balance
Within 1 year 190246472727342195114
1-2 years 72360621142097385184
2-3 years 2095989 Henan Huanghe Whirlwind Co.Ltd(600172) 9000300
More than 3 years 1809344830342521180
Total book balance of other receivables 3016604381611511101778
Less: bad debt reserves 52557844171993608123
The total book value of other receivables is 249102593999517493655
② Classification by nature of payment
